FR2807445A1 - PROCESS FOR STABILIZING AN ENZYME - Google Patents
PROCESS FOR STABILIZING AN ENZYME Download PDFInfo
- Publication number
- FR2807445A1 FR2807445A1 FR0004579A FR0004579A FR2807445A1 FR 2807445 A1 FR2807445 A1 FR 2807445A1 FR 0004579 A FR0004579 A FR 0004579A FR 0004579 A FR0004579 A FR 0004579A FR 2807445 A1 FR2807445 A1 FR 2807445A1
- Authority
- FR
- France
- Prior art keywords
- fatty acids
- weight
- enzyme
- oils
- fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 32
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000000087 stabilizing effect Effects 0.000 title claims abstract description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 29
- 239000000194 fatty acid Substances 0.000 claims abstract description 29
- 229930195729 fatty acid Natural products 0.000 claims abstract description 29
- 239000003921 oil Substances 0.000 claims abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 26
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 23
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims abstract description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 15
- 239000008158 vegetable oil Substances 0.000 claims abstract description 15
- -1 C24 fatty acids Chemical class 0.000 claims abstract description 10
- 235000021319 Palmitoleic acid Nutrition 0.000 claims abstract description 8
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract description 7
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- 239000012178 vegetable wax Substances 0.000 claims abstract description 5
- 239000001993 wax Substances 0.000 claims abstract description 4
- 150000002148 esters Chemical class 0.000 claims description 16
- 239000002480 mineral oil Substances 0.000 claims description 10
- 239000003349 gelling agent Substances 0.000 claims description 9
- 235000010446 mineral oil Nutrition 0.000 claims description 9
- 229920001296 polysiloxane Polymers 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000003445 sucroses Chemical class 0.000 claims description 2
- 150000005846 sugar alcohols Chemical class 0.000 claims description 2
- 235000021081 unsaturated fats Nutrition 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 10
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000208467 Macadamia Species 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 229940086555 cyclomethicone Drugs 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- 229920000926 Galactomannan Polymers 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 229920000289 Polyquaternium Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229940071160 cocoate Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 244000054471 Hiptage benghalensis Species 0.000 description 2
- 241001072282 Limnanthes Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- ULNRTPCFRBIMKL-GHVJWSGMSA-N (e)-2-tetracosenoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC\C=C\C(O)=O ULNRTPCFRBIMKL-GHVJWSGMSA-N 0.000 description 1
- ATNNLHXCRAAGJS-QZQOTICOSA-N (e)-docos-2-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCC\C=C\C(O)=O ATNNLHXCRAAGJS-QZQOTICOSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- NPDSHTNEKLQQIJ-SIGMCMEVSA-N 9-hode Chemical compound CCCCC\C=C\C=C\C(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-SIGMCMEVSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011309 Crambe hispanica subsp abyssinica Nutrition 0.000 description 1
- 241000220247 Crambe hispanica subsp. abyssinica Species 0.000 description 1
- OONXYOAWMIVMCI-UHFFFAOYSA-N D-Lesquerolinsaeure Natural products CCCCCCC(O)CC=CCCCCCCCCCC(O)=O OONXYOAWMIVMCI-UHFFFAOYSA-N 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000144217 Limnanthes alba Species 0.000 description 1
- 241001138417 Limnanthes douglasii Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 244000247850 Lunaria biennis Species 0.000 description 1
- 235000001154 Lunaria biennis Nutrition 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000893896 Physaria fendleri Species 0.000 description 1
- 241000694540 Pluvialis Species 0.000 description 1
- 235000003846 Ricinus Nutrition 0.000 description 1
- 241000322381 Ricinus <louse> Species 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- NPDSHTNEKLQQIJ-UHFFFAOYSA-N dimorphecolic acid Natural products CCCCCC=CC=CC(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-UHFFFAOYSA-N 0.000 description 1
- CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- OONXYOAWMIVMCI-KWRJMZDGSA-N lesquerolic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCCCC(O)=O OONXYOAWMIVMCI-KWRJMZDGSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- UWLFOQGWHRKPKJ-SSPAHAAFSA-N octadecanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.CCCCCCCCCCCCCCCCCC(O)=O UWLFOQGWHRKPKJ-SSPAHAAFSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- MBHCWRKFAXKMRT-UHFFFAOYSA-N propanoic acid;1-tetradecoxytetradecane Chemical compound CCC(O)=O.CCCCCCCCCCCCCCOCCCCCCCCCCCCCC MBHCWRKFAXKMRT-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne un procédé de stabilisation d'une enzyme, notamment en vue d'une application cosmétique, qui consiste à mélanger l'enzyme avec un véhicule contenant une quantité efficace d'une huile ou cire végétale choisie parmi :a) - les huiles triglycéridiques dont au moins 5% en poids des acides gras sont constitués d'acide palmitoléique;b) - les huiles triglycéridiques dont au moins 10% en poids des acides gras sont constitués par des acides gras hydroxylés;c) - les huiles triglycéridiques dont au moins 40% en poids des acides gras sont constitués par des acides gras en C20 à C24 mono- oudiinsaturés, d) - les huiles ou cires contenant au moins 50% en poids de monoesters d'acides gras ayant au total 36 à 46 atomes de carbone et dérivant d'un acide gras insaturé et d'un alcool gras insaturé.The present invention relates to a process for stabilizing an enzyme, in particular with a view to a cosmetic application, which consists in mixing the enzyme with a vehicle containing an effective amount of a vegetable oil or wax chosen from: a) - triglyceride oils of which at least 5% by weight of fatty acids consist of palmitoleic acid; b) - triglyceride oils of which at least 10% by weight of fatty acids consist of hydroxylated fatty acids; c) - triglyceride oils of which at least 40% by weight of the fatty acids consist of mono- or diunsaturated C20 to C24 fatty acids, d) - oils or waxes containing at least 50% by weight of fatty acid monoesters having in total 36 to 46 atoms of carbon and derived from an unsaturated fatty acid and an unsaturated fatty alcohol.
Description
i La présente invention concerne un procédé pour stabiliser une enzyme,i The present invention relates to a method for stabilizing an enzyme,
notamment en vue d'une application cosmétique. especially for cosmetic application.
On sait que les enzymes ont une stabilité limitée dans le temps lorsque We know that enzymes have limited stability over time when
l'on cherche à les incorporer dans des compositions cosmétiques. one seeks to incorporate them in cosmetic compositions.
On a donc déjà proposé différents procédés pour stabiliser des enzymes. L'une de ces méthodes consiste à conditionner l'enzyme dans une phase o l'enzyme est stable et à mélanger lors de l'utilisation cette phase avec une deuxième phase conditionnée séparément pour former une émulsion. Une telle méthode est décrite dans FR-A-2 163 348 (Richand), WO 96/10 990 (Knoll), WO 97/27 841 (GIST BROCADES), et WO 97/26 861 (NORD-MARK Various methods have therefore already been proposed for stabilizing enzymes. One of these methods consists in conditioning the enzyme in a phase where the enzyme is stable and in mixing during use this phase with a second phase conditioned separately to form an emulsion. Such a method is described in FR-A-2 163 348 (Richand), WO 96/10 990 (Knoll), WO 97/27 841 (GIST BROCADES), and WO 97/26 861 (NORD-MARK
ARZNEIMITTEL).ARZNEIMITTEL).
Une autre méthode, décrite dans FR 2 737 115 (L'OREAL), consiste à Another method, described in FR 2 737 115 (L'OREAL), consists in
diminuer l'activité de l'eau par utilisation de polyols. decrease the activity of water by using polyols.
Une autre méthode, décrite dans FR 2 732 593 (BIOEUROPE), consiste à Another method, described in FR 2 732 593 (BIOEUROPE), consists in
immobiliser l'enzyme sur des particules telles que des particules de silice. immobilizing the enzyme on particles such as silica particles.
A l'aide de tests de stabilité, les inventeurs ont maintenant mis en évidence le fait que les enzymes peuvent être stabilisées par certaines huiles végétales. La présente invention a ainsi pour objet un procédé de stabilisation d'une enzyme, notamment en vue d'une application cosmétique, qui consiste à mélanger l'enzyme avec un véhicule contenant une quantité efficace d'une huile ou cire végétale choisie parmi: a) - les huiles triglycéridiques dont au moins 5% en poids des acides gras sont constitués d'acide palmitoléique; b) - les huiles triglycéridiques dont au moins 10% en poids des acides gras sont constitués par des acides gras hydroxylés; c) - les huiles triglycéridiques dont au moins 40% en poids des acides gras sont constitués par des acides gras en C20 à C24 mono- ou di-insaturés, d) - les huiles ou cires contenant au moins 50% en poids de monoesters d'acides gras ayant au total 36 à 46 atomes de carbone et dérivant d'un acide With the aid of stability tests, the inventors have now demonstrated that the enzymes can be stabilized by certain vegetable oils. A subject of the present invention is thus a method for stabilizing an enzyme, in particular with a view to cosmetic application, which consists in mixing the enzyme with a vehicle containing an effective amount of a vegetable oil or wax chosen from: a ) - triglyceride oils of which at least 5% by weight of fatty acids consist of palmitoleic acid; b) - triglyceride oils of which at least 10% by weight of the fatty acids consist of hydroxylated fatty acids; c) - triglyceride oils of which at least 40% by weight of fatty acids consist of C20 to C24 fatty acids mono- or di-unsaturated, d) - oils or waxes containing at least 50% by weight of monoesters d fatty acids having a total of 36 to 46 carbon atoms and derived from an acid
gras insaturé et d'un alcool gras insaturé. unsaturated fat and an unsaturated fatty alcohol.
L'huile ou cire végétale spécifique est avantageusement présente en une proportion en poids par rapport à l'enzyme d'au moins 4/1 et, de préférence, de The specific vegetable oil or wax is advantageously present in a proportion by weight relative to the enzyme of at least 4/1 and, preferably, of
/1 à 60/1./ 1 to 60/1.
Les huiles ou cires végétales spécifiques qui sont utilisées dans la présente invention appartiennent à 4 classes spécifiques: a- les huiles triglycéridiques dont au moins 5% en poids des acides The specific vegetable oils or waxes which are used in the present invention belong to 4 specific classes: a- triglyceride oils of which at least 5% by weight of the acids
gras sont constitués d'acide palmitoléique. Fats are made up of palmitoleic acid.
Comme exemples on peut citer les huiles suivantes: * macadamia (contenant de 20 à 25% d'acide palmitoléique), 10. aveline (contenant de 22 à 29% d'acide palmitoléique), * argousier (contenant de 20 à 30% d'acide palmitoléique), Examples include the following oils: * macadamia (containing 20 to 25% palmitoleic acid), 10. oatmeal (containing 22 to 29% palmitoleic acid), * sea buckthorn (containing 20 to 30% d 'palmitoleic acid),
À avocat (contenant de 5 à 10% d'acide palmitoléique). Avocado (containing 5 to 10% palmitoleic acid).
b- Les huiles triglycéridiques dont au moins 10% en poids des acides b- Triglyceride oils of which at least 10% by weight of acids
gras sont constitués par des acides gras hydroxylés. Fats are made up of hydroxy fatty acids.
Les acides gras hydroxylés sont essentiellement l'acide ricinoléique (OH C18:1), I'acide dimorphécolique (OH C18:2) et l'acide lesquerolique (OH The hydroxylated fatty acids are essentially ricinoleic acid (OH C18: 1), dimorphecolic acid (OH C18: 2) and lesquerolic acid (OH
C20:1).C20: 1).
Comme exemples on peut citer les huiles des espèces suivantes: Ricin (Ricinus communis) 85 à 90% de OH C18:1 Ricinus zanzibarinus 90% de OH C18:1 Hiptage madablota 70% de OH C18:1 Hiptage benghalensis 85% de OH C18:1 Dimorphoteca pluvialis 62% de OH C18:2 Osteopermum ecklonis 72% de OH C18:2 Lesquerella fendleri, et autres Examples include the oils of the following species: Castor oil (Ricinus communis) 85 to 90% of OH C18: 1 Ricinus zanzibarinus 90% of OH C18: 1 Hiptage madablota 70% of OH C18: 1 Hiptage benghalensis 85% of OH C18 : 1 Dimorphoteca pluvialis 62% OH C18: 2 Osteopermum ecklonis 72% OH C18: 2 Lesquerella fendleri, and others
espèces du même genre 57% de OH C20:1. species of the same genus 57% of OH C20: 1.
c- Les huiles triglycéridiques dont au moins 40% en poids des acides c- Triglyceride oils of which at least 40% by weight of acids
gras sont constitués par des acides gras en C20-C24 mono- ou di-insaturés. Fats are made up of mono- or di-unsaturated C20-C24 fatty acids.
Ces acides gras sont essentiellement l'acide eicosanoïque (C20:1 A13), I'acide eicosénoïque (C22:1 A5), I'acide docosénoïque ou acide érucique (C22:1 A13), l'acide docosanediénoïque (C22:2 A5, A13), l'acide tétracosénoïque These fatty acids are essentially eicosanoic acid (C20: 1 A13), eicosenoic acid (C22: 1 A5), docosenoic acid or erucic acid (C22: 1 A13), docosanedienoic acid (C22: 2 A5 , A13), tetracosenoic acid
(C24:1).(C24: 1).
Comme exemples, on peut citer les huiles des espèces suivantes: Limnanthe (Limnanthes alba) contenant 62,5% de C20:1 A13 L. douglasii contenant 62, 5% de C20:1 A13 Brassica napus contenant 45% de C22:1 A13 Crambe abyssinica contenant 55% de C22:1 A13 Eruca sativa contenant 45% de C22:1 A13 As examples, there may be mentioned the oils of the following species: Limnanthe (Limnanthes alba) containing 62.5% of C20: 1 A13 L. douglasii containing 62.5% of C20: 1 A13 Brassica napus containing 45% of C22: 1 A13 Crambe abyssinica containing 55% C22: 1 A13 Eruca sativa containing 45% C22: 1 A13
Lunaria annua contenant 43% de C22:1 A13. Lunaria annua containing 43% of C22: 1 A13.
d- Les huiles ou cires contenant au moins 50% en poids de monoesters d'acides gras ayant au total 36 à 46 atomes de carbone et dérivant d- Oils or waxes containing at least 50% by weight of fatty acid monoesters having a total of 36 to 46 carbon atoms and derived
d'un acide gras insaturé et d'un alcool gras insaturé. an unsaturated fatty acid and an unsaturated fatty alcohol.
Comme exemple, on peut citer l'huile de jojoba dont les deux principaux acides gras sont les suivants: As an example, mention may be made of jojoba oil, the two main fatty acids of which are as follows:
C20:1 70 à 75%C20: 1 70 to 75%
C22:1 0 à 15%,C22: 1 0 to 15%,
et les deux principaux alcanols sont les suivants and the two main alkanols are as follows
C20:1 50%C20: 1 50%
C22:1 40%.C22: 1 40%.
Les enzymes qui peuvent être stabilisées selon la présente invention peuvent être de différents types (protéases, lipases, phospholipases, phosphatases), de toute origine (biotechnologique, bactérienne, fongique, The enzymes which can be stabilized according to the present invention can be of different types (proteases, lipases, phospholipases, phosphatases), of any origin (biotechnological, bacterial, fungal,
végétale) et sous toute forme (poudre, liquide, immobilisée, vectorisée). vegetable) and in any form (powder, liquid, immobilized, vectorized).
Le véhicule utilisé dans la présente invention peut en outre contenir une huile minérale qui peut être présente en une proportion en poids par rapport à The vehicle used in the present invention may also contain a mineral oil which may be present in a proportion by weight relative to
l'enzyme d'au moins 10/1.the enzyme at least 10/1.
Comme exemples d'huiles minérales, on peut citer les huiles de paraffine Examples of mineral oils include paraffin oils
et les huiles de vaseline.and petrolatum oils.
Le véhicule utilisé dans la présente invention peut en outre contenir une silicone, notamment des huiles de type polydiméthylsiloxanes (telles que diméthicones, diméthiconols), des huiles polydiméthylsiloxanes modifiées (telles que diméthicone copolyols), ou des silicones volatiles (telles que que The vehicle used in the present invention may also contain a silicone, in particular oils of the polydimethylsiloxane type (such as dimethicones, dimethiconols), modified polydimethylsiloxane oils (such as dimethicone copolyols), or volatile silicones (such as
cyclométhicones).cyclomethicones).
Le véhicule utilisé dans la présente invention peut en outre contenir un ester choisi parmi les esters d'alcools gras (en C4-C36), les esters d'acides gras (en C4-C36), les esters polyoxyéthyléniques d'acides gras et d'alcools gras tels The vehicle used in the present invention may also contain an ester chosen from fatty alcohol esters (C4-C36), fatty acid esters (C4-C36), polyoxyethylenic esters of fatty acids and d fatty alcohols such
que Steareth 21, Isoceteth 20, les esters de polyalcools tels que myreth3- as Steareth 21, Isoceteth 20, esters of polyalcohols such as myreth3-
myristate, polypropylène glycol - 2 myristyl éther propionate, les esters de myristate, polypropylene glycol - 2 myristyl ether propionate, esters of
sucroses tels que stéarate de glucose, sesquistéarate de méthyl glucose. sucroses such as glucose stearate, methyl glucose sesquistearate.
Le véhicule utilisé dans la présente invention peut en outre contenir un agent gélifiant. Comme exemple, on peut citer l'hydroxypropylméthylcellulose et l'hydroxyéthylcellulose, les gommes xanthane, les alginates, les carbomeres (par exemple Carbopol 1382), les Polyquaterniums tels que Polyquaternium 32, The vehicle used in the present invention may further contain a gelling agent. As an example, mention may be made of hydroxypropylmethylcellulose and hydroxyethylcellulose, xanthan gums, alginates, carbomers (for example Carbopol 1382), Polyquaterniums such as Polyquaternium 32,
Polyquaternium 39.Polyquaternium 39.
Des compositions d'enzymes stabilisées selon la présente invention 1o peuvent contenir notamment: 0,1 à 5 % en poids d'enzyme, 2 à 50% en poids d'huile végétale spécifique, à 50% en poids d'huile minérale, 1 à 20% en poids de silicone, 1 à 30% en poids d'agent gélifiant, Stabilized enzyme compositions according to the present invention 1o may contain in particular: 0.1 to 5% by weight of enzyme, 2 to 50% by weight of specific vegetable oil, to 50% by weight of mineral oil, 1 20% by weight of silicone, 1 to 30% by weight of gelling agent,
1 à 30% d'ester.1 to 30% of ester.
On donnera ci-après des résultats d'essais in vitro montrant l'effet de stabilisation des huiles végétales spécifiques dans des compositions de type In vitro test results will be given below showing the stabilizing effect of specific vegetable oils in compositions of the type
cosmétique et l'effet des constituants complémentaires. cosmetic and the effect of complementary constituents.
On mesure l'activité protéolytique d'une protéase (Kératoline de la société Sederma), enzyme de type subtilisine, par hydrolyse in vitro de la caséine. Après hydrolyse, les protéines restantes sont précipitées par l'acide. Le dosage des peptides libérés se fait d'après la méthode de Lowery modifiée: en milieu alcalin, les ions Cu2+ du réactif de Folin forment avec les liaisons amides des peptides un complexe coloré en bleu, que l'on mesure à 660 nm. L'intensité de l'hydrolyse est The proteolytic activity of a protease (Keratoline from the company Sederma), an enzyme of the subtilisin type, is measured by in vitro hydrolysis of casein. After hydrolysis, the remaining proteins are precipitated by the acid. The assay of the released peptides is carried out according to the modified Lowery method: in an alkaline medium, the Cu2 + ions of the Folin reagent form with the amide bonds of the peptides a complex colored in blue, which is measured at 660 nm. The intensity of the hydrolysis is
proportionnelle à la valeur de la densité optique. proportional to the value of the optical density.
Les compositions testées étaient les suivantes Enzyme (Keratoline) 0,5 % Huile végétale 30,0 % Huile minérale (isohexadécane) 38,9 % Gélifiant (galactomannane) 3,0 % Silice 2,0 % Silicone (cyclomethicone) 10,0 % Antioxydant (acétate de tocophérol) 0,1 % Ester (benzoate d'alkyle (C12 C15)) 15,0 % Parfum 0,5 % Résultats Des mesures ont été effectuées au bout de 15 jours et de 1 mois afin d'observer l'évolution de l'activité enzymatique dans le temps. On obtient les résultats suivants: Huiles selon macadamia Limnanthes jojoba ricin l'invention The compositions tested were the following Enzyme (Keratoline) 0.5% Vegetable oil 30.0% Mineral oil (isohexadecane) 38.9% Gelling agent (galactomannan) 3.0% Silica 2.0% Silicone (cyclomethicone) 10.0% Antioxidant (tocopherol acetate) 0.1% Ester (alkyl benzoate (C12 C15)) 15.0% Fragrance 0.5% Results Measurements were taken after 15 days and 1 month to observe the evolution of enzyme activity over time. The following results are obtained: Oils according to macadamia Limnanthes jojoba castor the invention
DO (TO) 0,68 0,83 1,29 0,45DO (TO) 0.68 0.83 1.29 0.45
DO (15 jours) 0,50 0,77 0,97 0,42 DO (1 mois) 0,46 0,54 0,70 0,39 Autres huiles palme raisin amande douce DO (15 days) 0.50 0.77 0.97 0.42 DO (1 month) 0.46 0.54 0.70 0.39 Other palm grape sweet almond oils
DO (T10O) 0,03 0,18 0,30DO (T10O) 0.03 0.18 0.30
DO (15 jours) 0,00 0,14 0,23 DO (1 mois) 0,00 0,00 Il apparaît donc que des huiles végétales spécifiques selon l'invention sont l0 tout-à-fait adaptées pour préserver l'activité d'une enzyme dans le temps dans un produit fini. En revanche, les autres huiles (palme, raisin, amande douce) , soit détruisent dès le début les enzymes, soit ne permettent pas de conserver DO (15 days) 0.00 0.14 0.23 DO (1 month) 0.00 0.00 It therefore appears that specific vegetable oils according to the invention are perfectly suited to preserve the activity of an enzyme over time in a finished product. On the other hand, the other oils (palm, grape, sweet almond), either destroy the enzymes from the start, or do not allow to preserve
l'activité enzymatique.enzyme activity.
D'autres essais ont été effectués avec des constituants complémentaires. Other tests have been carried out with additional constituents.
Les compositions testées étaient les suivantes: 1 2 3 4 Enzyme (keratoline) 0,5 % 0,5 % 0,5 % 0,5 % Huile de macadamia 30,0 % 0,00 0,00 0,00 Huile minérale (isohexadécane) 38,9% 68,9 % 38,9 % 38,9 % Gélifiant (galactomannane) 3,0 % 3,0 % 3,0 % 3,0 % Silice 2,0 % 2,0 % 2,0 % 2,0% Silicone (cyclométhicone) 10,0 % 10,0 % 40 % 10,0 % Antioxydant (acétate de tocothérol) 0,1 % 0,1 % 0,1 % 0,1 % 6 Ester (Benzoate d'alkyle (C12 C15) 15,0 % 15,0 % 15,0 % 45 % Parfum 0,5 % 0,5 % 0,5 % 0,5 % Les résultats étaient les suivants: Composition Référence DO (TO) DO (15 jours) %/T0 1 macadamia 0,68 0,50 73,5 The compositions tested were as follows: 1 2 3 4 Enzyme (keratoline) 0.5% 0.5% 0.5% 0.5% Macadamia oil 30.0% 0.00 0.00 0.00 Mineral oil ( isohexadecane) 38.9% 68.9% 38.9% 38.9% Gelling agent (galactomannan) 3.0% 3.0% 3.0% 3.0% Silica 2.0% 2.0% 2.0 % 2.0% Silicone (cyclomethicone) 10.0% 10.0% 40% 10.0% Antioxidant (tocoterol acetate) 0.1% 0.1% 0.1% 0.1% 6 Ester (Benzoate d '' alkyl (C12 C15) 15.0% 15.0% 15.0% 45% Perfume 0.5% 0.5% 0.5% 0.5% The results were as follows: Composition Reference DO (TO) DO (15 days)% / T0 1 macadamia 0.68 0.50 73.5
2 huile minérale 0,92 NA * -2 mineral oil 0.92 NA * -
3 huile de silicone 0,55 NA * 4 ester 0,32 0,12 3 silicone oil 0.55 NA * 4 ester 0.32 0.12
* NA: non accessible car séparation de phase. * NA: not accessible because phase separation.
Il apparaît clairement que le remplacement de l'huile de macadémia par une huile minérale, une huile de silicone ou un ester, ne permet pas de It is clear that replacing macademia oil with mineral oil, silicone oil or an ester does not allow
stabiliser la composition à base d'enzyme. stabilize the enzyme composition.
On donnera ci-après d'autres exemples concrets de compositions Other concrete examples of compositions will be given below.
stabilisées selon le procédé de l'invention. stabilized according to the process of the invention.
Exemple I: Lait VISAGE Une formule lait visage a été conditionné dans un packaging bi-pack, les deux compartiments ne se mélangeant qu'au moment de l'emploi, de façon à Example I: FACE milk A face milk formula was packaged in a bi-pack packaging, the two compartments mixing only at the time of use, so as to
former une émulsion sur la peau.form an emulsion on the skin.
La composition d'une première phase de type gel anhydre est la suivante: Enzyme (Keratoline) 0,5 % Huile végétale 30,0 % Huile minérale (isohexadécane) 38,9 % Gélifiant (galactomannane) 3,0 % Silice 2,0 % Silicone (cyclomethicone) 10,0 % Antioxydant (acétate de tocophérol) 0,1 % Ester (benzoate d'alkyle (C12 -C15) 15,0 % La composition de la deuxième phase (de type émulsion) est la suivante: Eau déminéralisée 54, 450 Sequestrant (Na4 EDTA) 0,025 Adoucissant (Allantoïne) 0,200 Gélifiant (Gomme xanthane) 4,075 Ester (Cocoate) 8,000 Conservaeurs (POBM) 1,650 Huile végétale (macadamia) 4,000 Antioxydant (acétate de tocophérol) 0, 200 Emulsion (Stéareth...) 4,100 Silice 1,000 Eau déminéralisée 8,000 Hydratant (Glycérine) 10,000 Sorbaïne 0,600 Complexe au Pro-Rétinol végétal 0,200 Vitamines (Palmitate de vit.A, Vit.E) 0,200 Parfum 0,300 Ethanol 3,000 Exemple 2: Cake (Poudre coulée) Ester (Cocoate) 20,400 Paraffine 65 5,000 Filtres solaires 1,000 Triglycéride 8,000 Huile végétale (macadamia) 9,500 Emulsifiants (Lécithine de soja) 1,500 Antioxydant (acétate de tocophérol) 0,100 Silicone 7,000 Enzyme (protéase) 0,600 Hydratant (glycérine) 6,000 Silice 5,000 Parfum 0,200 Charges (TiO2) 27,500 Gélifiant (Bentone) 1,200 Nacre 7,000 Exemple 3: Emulsion VISAGE et CORPS Eau déminéralisée 60,575 Humectant (Propylène glycol) 2, 000 Hydratant (Glycérine) 2,000 Séquestrant (Na 4 EDTA) 0,025 Gélifiants (Alginate) 0,100 Conservateur (POBM) 0,200 Antioxydant (acétate de tocophérol) 0,100 Huile végétale (macadamia) 12,000 Silicone (Cyclométhicone) 3,000 Tryglicéride 2,000 Adoucissants (Bisabolol) 0,100 Epaissisant (Acide gras) 1,500 Emulsifiants (Alcool gras) 4,000 Ester (Cocoate) 7,000 Enzymes (protéases) 1,100 Parfum 0,300 Ethanol 3,000 Silice 1,000 The composition of a first phase of anhydrous gel type is as follows: Enzyme (Keratoline) 0.5% Vegetable oil 30.0% Mineral oil (isohexadecane) 38.9% Gelling agent (galactomannan) 3.0% Silica 2.0 % Silicone (cyclomethicone) 10.0% Antioxidant (tocopherol acetate) 0.1% Ester (alkyl benzoate (C12 -C15) 15.0% The composition of the second phase (emulsion type) is as follows: Water demineralized 54, 450 Sequestrant (Na4 EDTA) 0.025 Softener (Allantoin) 0.200 Gelling agent (Xanthan gum) 4.075 Ester (Cocoate) 8,000 Preservatives (POBM) 1.650 Vegetable oil (macadamia) 4,000 Antioxidant (tocopherol acetate) 0, 200 Emulsion (Steareth. ..) 4,100 Silica 1,000 Demineralized Water 8,000 Moisturizer (Glycerin) 10,000 Sorbaine 0.600 Plant-Pro-Retinol Complex 0.200 Vitamins (Palmitate of Vit.A, Vit.E) 0.200 Fragrance 0.300 Ethanol 3,000 Example 2: Cake (Cast powder) Ester ( Cocoate) 20,400 Paraffin 65 5,000 Sunscreens 1,000 Triglyceride 8.0 00 Vegetable oil (macadamia) 9,500 Emulsifiers (Soy lecithin) 1,500 Antioxidant (tocopherol acetate) 0.100 Silicone 7,000 Enzyme (protease) 0.600 Moisturizer (glycerin) 6,000 Silica 5,000 Perfume 0.200 Fillers (TiO2) 27,500 Gelling agent (Bentone) 1,200 Nacre 7,000 Example 3: FACE and BODY emulsion Demineralized water 60,575 Humectant (Propylene glycol) 2,000 Moisturizer (Glycerin) 2,000 Sequestrant (Na 4 EDTA) 0.025 Gelling agents (Alginate) 0.100 Preservative (POBM) 0.200 Antioxidant (tocopherol acetate) 0.100 Vegetable oil (macadamia ) 12,000 Silicone (Cyclomethicone) 3,000 Trygliceride 2,000 Softeners (Bisabolol) 0.100 Thickener (Fatty Acid) 1,500 Emulsifiers (Fatty Alcohol) 4,000 Ester (Cocoate) 7,000 Enzymes (Proteases) 1,100 Perfume 0.300 Ethanol 3,000 Silica 1,000
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0004579A FR2807445B1 (en) | 2000-04-10 | 2000-04-10 | PROCESS FOR STABILIZING AN ENZYME |
DE2000139206 DE10039206A1 (en) | 2000-04-10 | 2000-08-10 | Stabilization of enzymes, especially in cosmetic compositions, comprises mixing the enzyme with a carrier comprising a selected vegetable oil or wax |
AT17402000A AT410752B (en) | 2000-04-10 | 2000-10-12 | USE OF A VEGETABLE OIL OR WAX FOR STABILIZING ENZYMES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0004579A FR2807445B1 (en) | 2000-04-10 | 2000-04-10 | PROCESS FOR STABILIZING AN ENZYME |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2807445A1 true FR2807445A1 (en) | 2001-10-12 |
FR2807445B1 FR2807445B1 (en) | 2002-07-05 |
Family
ID=8849084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0004579A Expired - Fee Related FR2807445B1 (en) | 2000-04-10 | 2000-04-10 | PROCESS FOR STABILIZING AN ENZYME |
Country Status (3)
Country | Link |
---|---|
AT (1) | AT410752B (en) |
DE (1) | DE10039206A1 (en) |
FR (1) | FR2807445B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1588173A (en) * | 1966-11-09 | 1970-04-10 | ||
US3860702A (en) * | 1972-07-11 | 1975-01-14 | Schuyler Dev Corp | Anti-inflammatory compositions |
EP0274431A2 (en) * | 1987-01-08 | 1988-07-13 | Quixote Corporation | Drug delivery compositions and methods |
EP0294520A1 (en) * | 1985-12-07 | 1988-12-14 | Fuji Oil Company, Limited | Process for preparing enzyme preparation |
US5830449A (en) * | 1995-07-25 | 1998-11-03 | L'oreal | Stable composition containing an enzyme |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU562281A1 (en) * | 1974-10-01 | 1977-06-25 | Всесоюзный Научно-Исследовательский Биотехнический Институт | Cream for dry skin |
JPS57120507A (en) * | 1981-01-19 | 1982-07-27 | Tadashi Hakamata | Powdery base cosmetic |
JPS58180410A (en) * | 1982-04-16 | 1983-10-21 | Shiseido Co Ltd | Cosmetic |
SU1165397A1 (en) * | 1983-10-25 | 1985-07-07 | Московский Научно-Исследовательский Институт Косметологии | Agent for prophylaxis and treatment of hypertrophic and keloid cicatrixes |
JP2651992B2 (en) * | 1993-08-24 | 1997-09-10 | 株式会社粘土科学研究所 | Bath additive |
RU2089177C1 (en) * | 1994-02-03 | 1997-09-10 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Agent for skin care |
CN1112827A (en) * | 1994-05-30 | 1995-12-06 | 乌力吉 | Long lasting multi-function nutritive cream for skin care containing extract of Chinese soft shelled turtle and the prepn. method |
JPH08217659A (en) * | 1995-02-17 | 1996-08-27 | Kobe Steel Ltd | Method for decoloring mlanin |
JP3080877B2 (en) * | 1996-03-18 | 2000-08-28 | 鐘紡株式会社 | Wax capsule and cleaning composition |
-
2000
- 2000-04-10 FR FR0004579A patent/FR2807445B1/en not_active Expired - Fee Related
- 2000-08-10 DE DE2000139206 patent/DE10039206A1/en not_active Ceased
- 2000-10-12 AT AT17402000A patent/AT410752B/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1588173A (en) * | 1966-11-09 | 1970-04-10 | ||
US3860702A (en) * | 1972-07-11 | 1975-01-14 | Schuyler Dev Corp | Anti-inflammatory compositions |
EP0294520A1 (en) * | 1985-12-07 | 1988-12-14 | Fuji Oil Company, Limited | Process for preparing enzyme preparation |
EP0274431A2 (en) * | 1987-01-08 | 1988-07-13 | Quixote Corporation | Drug delivery compositions and methods |
US5830449A (en) * | 1995-07-25 | 1998-11-03 | L'oreal | Stable composition containing an enzyme |
Also Published As
Publication number | Publication date |
---|---|
ATA17402000A (en) | 2002-12-15 |
FR2807445B1 (en) | 2002-07-05 |
DE10039206A1 (en) | 2001-10-18 |
AT410752B (en) | 2003-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011332251B2 (en) | Moisturizing compositions for lip | |
EP0692236B1 (en) | Cleaning composition containing lipidic grains | |
CA1267365A (en) | Cosmetic composition based on vegetable extracts soluble in oil to promote slimming by heat action | |
CA2132369C (en) | Use for the treatment of mixed skins, of an effective quantity of active substances | |
US5079003A (en) | Skin lotions and creams | |
FR2788058A1 (en) | SLIMMING COSMETIC COMPOSITIONS | |
CH646879A5 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS IN THE FORM OF STABLE OIL-IN-WATER EMULSIONS. | |
FR2585568A1 (en) | COSMETIC COMPOSITIONS COMPRISING LIPID DERIVED FROM CORNEAL CELLS | |
WO2000004047A1 (en) | Cosmetic compositions for slimming | |
EP0713696B1 (en) | Topical application product containing a lipase and a precursor of hydroxyacid | |
FR2851460A1 (en) | USE OF N-LAUROYL AMINOACIDS AS A SLIMMING COSMETIC AND PHARMACEUTICAL ACTIVE | |
FR2807445A1 (en) | PROCESS FOR STABILIZING AN ENZYME | |
FR2787709A1 (en) | NOVEL DERMATOLOGICAL COMPOSITION BASED ON TANNIC ACID AND A MICROBIAL PROLIFERATION INHIBITOR | |
EP0862913A1 (en) | Oily homogeneous composition based on silicone gum | |
FR2666809A1 (en) | ANTI-OXIDIZING SYSTEM BASED ON A BASIC AMINO ACID IN ASSOCIATION WITH AT LEAST ONE TOCOPHEROL OR AND ITS DERIVATIVES AND AT LEAST ONE NON-THIOLE POLYPEPTIDE AND COMPOSITIONS CONTAINING SUCH AN ANTI-OXIDIZING SYSTEM | |
FR3117834A1 (en) | Biphase cosmetic composition comprising an amino acid and two specific acids | |
JP2006298814A (en) | Skin lotion for acne | |
FR2851461A1 (en) | USE OF N-OCTANOYL AMINOACIDS AS A COSMETIC AND PHARMACEUTICAL ACTIVE SLIMMING | |
JP2628328B2 (en) | Whitening cosmetics | |
FR2993466A1 (en) | USE OF A PROTECTIVE CREAM AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN | |
FR3148145A1 (en) | CARE COMPOSITION OF KERATINOUS MATERIALS | |
FR2822702A1 (en) | Stable oil-based liquid cosmetic composition, useful for preventing chapping, comprises an animal or vegetable oil, panthenol, a glycol and a monohydric alcohol | |
FR3021214A1 (en) | COMPOSITION COMPRISING A DYARBOXYLIC PYRIDINE ACID ESTER, A SURFACTANT AND A LIQUID MONOALCOOL, PROCESS AND USE | |
WO2020030367A1 (en) | Anhydrous cosmetic composition comprising vegetable oil | |
WO2009002208A1 (en) | Microbiotic collagenase-based cosmetic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 16 |
|
ST | Notification of lapse |
Effective date: 20161230 |